Log in

Citric acid-based bicarbonate dialysate attenuates aortic arch calcification in maintenance hemodialysis patients: a retrospective observational study

  • original Article
  • Published:
Journal of Nephrology Aims and scope Submit manuscript

Abstract

Background

Progression of aortic calcification is associated with all-cause and cardiovascular mortality in hemodialysis patients. Blood calciprotein particle (CPP) levels are associated with coronary artery calcification and were reported to be inhibited when using citric acid-based bicarbonate dialysate (CD). Therefore, this study aimed to examine the effect of CD on the progression of the aortic arch calcification score (AoACS) and blood CPP levels in hemodialysis patients.

Methods

A 12-month retrospective observational study of 262 hemodialysis patients was conducted. AoACS was evaluated by calculating the number of calcifications in 16 segments of the aortic arch on chest X-ray (minimum score is 0; maximum score is 16 points). The patients were divided into the following groups according to their baseline AoACS: grade 0, AoACS = 0 points; grade 1, AoACS 1–4 points; grade 2, AoACS 5–8 points; grade 3, AoACS 9 points or higher. Patients on bisphosphonates or warfarin or with AoACS grade 3 were excluded. Progression, defined as ΔAoACS (12-month score – baseline score) > 0 points, was compared between the CD and acetic acid-based bicarbonate dialysate (AD) groups before and after adjusting the background using propensity score matching.

Results

The AoACS progression rate was significantly lower in the CD group than in the AD group (before matching: P = 0.020, after matching: P = 0.002). Multivariate logistic regression analysis showed that CD was significantly associated with AoACS progression (odds ratio 0.52, 95% confidence interval 0.29‒0.92, P = 0.025).

Conclusion

CD may slow the progression of vascular calcification in hemodialysis patients.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Chronic Kidney Disease Prognosis Consortium (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375:2073–2081. https://doi.org/10.1016/S0140-6736(10)60674-5

    Article  Google Scholar 

  2. Ogawa T, Ishida H, Matsuda N, Fujiu A, Matsuda A, Ito K, Ando Y, Nitta K (2009) Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients. Hemodial Int 13:301–306. https://doi.org/10.1111/j.1542-4758.2009.00366.x

    Article  PubMed  Google Scholar 

  3. Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, Ando Y, Nitta K (2010) Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol 42:187–194. https://doi.org/10.1007/s11255-009-9574-5

    Article  PubMed  Google Scholar 

  4. Abdelmalek JA, Stark P, Walther CP, Ix JH, Rifkin DE (2012) Associations between coronary calcification on chest radiographs and mortality in hemodialysis patients. Am J Kidney Dis 60:990–997. https://doi.org/10.1053/j.ajkd.2012.06.018

    Article  PubMed Central  PubMed  Google Scholar 

  5. Komatsu M, Okazaki M, Tsuchiya K, Kawaguchi H, Nitta K (2014) Aortic arch calcification predicts cardiovascular and all-cause mortality in maintenance hemodialysis patients. Kidney Blood Press Res 39:658–667. https://doi.org/10.1159/000368476

    Article  CAS  PubMed  Google Scholar 

  6. Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker FW, Ketteler M, Schurgers LJ, Krediet RT, Korevaar JC, NECOSAD Study Group (2011) Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 26:1662–1669. https://doi.org/10.1093/ndt/gfq582

    Article  PubMed  Google Scholar 

  7. Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y (2010) Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol 21:1998–2007. https://doi.org/10.1681/ASN.2009090944

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Smith ER, Ford ML, Tomlinson LA, Rajkumar C, McMahon LP, Holt SG (2012) Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD. Nephrol Dial Transplant 27:1957–1966. https://doi.org/10.1093/ndt/gfr609

    Article  CAS  PubMed  Google Scholar 

  9. Heiss A, DuChesne A, Denecke B, Grötzinger J, Yamamoto K, Renné T, Jahnen-Dechent W (2003) Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem 278:13333–13341. https://doi.org/10.1074/jbc.M210868200

    Article  CAS  PubMed  Google Scholar 

  10. Schäfer C, Heiss A, Schwarz A, Westenfeld R, Ketteler M, Floege J, Muller-Esterl W, Schinke T, Jahnen-Dechent W (2003) The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 112:357–366. https://doi.org/10.1172/JCI17202

    Article  PubMed Central  PubMed  Google Scholar 

  11. Akiyama KI, Miura Y, Hayashi H, Sakata A, Matsumura Y, Kojima M, Tsuchiya K, Nitta K, Shiizaki K, Kurosu H, Kuro-O M (2020) Calciprotein particles regulate fibroblast growth factor-23 expression in osteoblasts. Kidney Int 97:702–712. https://doi.org/10.1016/j.kint.2019.10.019

    Article  CAS  PubMed  Google Scholar 

  12. Miura Y, Iwazu Y, Shiizaki K, Akimoto T, Kotani K, Kurabayashi M, Kurosu H, Kuro-O M (2018) Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease. Sci Rep 8:1256. https://doi.org/10.1038/s41598-018-19677-4

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Fusaro M, Tripepi G, Noale M, Plebani M, Zaninotto M, Piccoli A, Naso A, Miozzo D, Giannini S, Avolio M, Foschi A, Rizzo MA, Gallieni M (2015) Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol 13:248–258. https://doi.org/10.2174/15701611113119990146

    Article  CAS  PubMed  Google Scholar 

  14. Nitta K, Akiba T, Suzuki K, Uchida K, Watanabe R, Majima K, Aoki T, Nihei H (2004) Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis 44:680–688. https://doi.org/10.1016/S0272-6386(04)00937-0

    Article  CAS  PubMed  Google Scholar 

  15. Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Rakugi H, Imai E, Isaka Y (2009) Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int 75:915–928. https://doi.org/10.1038/ki.2008.700

    Article  CAS  PubMed  Google Scholar 

  16. Nakazato J, Hoshide S, Wake M, Miura Y, Kuro-O M, Kario K (2019) Association of calciprotein particles measured by a new method with coronary artery plaque in patients with coronary artery plaque in patients with coronary artery disease: a cross sectional study. J Cardiol 74:428–435. https://doi.org/10.1016/j.jjcc.2019.04.008

    Article  PubMed  Google Scholar 

  17. Ter Meulen KJ, Dekker MJ, Pasch A, Broers NJH, van der Sande FM, van der Net JB, Konings CJAM, Gsponer IM, Bachtler MDN, Gauly A, Canaud B, Kooman JP (2019) Citric-acid dialysate improves the calcification propensity of hemodialysis patients: a multicenter prospective randomized cross- over trial. PLoS One 14:e0225824. https://doi.org/10.1371/journal.pone.0225824

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Lorenz G, Mayer CC, Bachmann Q, Stryeck S, Braunisch MC, Haller B, Carbajo-Lozoya J, Schmidt A, Witthauer S, Abuzahu J, Kemmner S, Angermann S, Koneru N, Wassertheurer S, Bieber R, Heemann U, Madl T, Pasch A, Schmaderer C (2018) Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity—a preliminary study. Nephrol Dial Transplant 33:2043–2051. https://doi.org/10.1093/ndt/gfy134

    Article  CAS  PubMed  Google Scholar 

  19. Yamada S, Giachelli CM (2017) Vascular calcification in CKD-MBD: roles for phosphate, FGF23, and Klotho. Bone 100:87–93. https://doi.org/10.1016/j.bone.2016.11.012

    Article  CAS  PubMed  Google Scholar 

  20. Villa-Bellosta R, Hernández-Martínez E, Mérida-Herrero E, González-Parra E (2019) Impact of acetate- or citrate-acidified bicarbonate dialysate on ex vivo aorta wall calcification. Sci Rep 9:11374. https://doi.org/10.1038/s41598-019-47934-7

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Schmitz M, Loke O, Fach B, Kalb K, Heering PJ, Meinke D, Rawer P, Galle J, Kozik-Jaromin J (2016) Effects of citrate dialysate in chronic dialysis: a multicentre randomized crossover study. Nephrol Dial Transplant 31:1327–1334. https://doi.org/10.1093/ndt/gfv347

    Article  PubMed  Google Scholar 

  22. Masuda A, Hagiwara S, Tanimoto M, Kodama F, Okumura K, Nohara N, Matsumoto M, Maiguma M, Omote K, Io H, Kurusu A, Ohsawa I, Shimizu Y, Hamada C, Horikoshi S, Tomino Y (2012) Effects of acetate-free citrate dialysate on glycoxidation and lipid peroxidation products in hemodialysis patients. Nephron Extra 2:256–268. https://doi.org/10.1159/000342258

    Article  PubMed Central  PubMed  Google Scholar 

  23. Taki K, Takayama F, Tsuruta Y, Niwa T (2006) Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 70:218–224. https://doi.org/10.1038/sj.ki.5000330

    Article  CAS  PubMed  Google Scholar 

  24. Yamamoto Y, Sakata N, Meng J, Sakamoto M, Noma A, Maeda I, Okamoto K, Takebayashi S (2002) Possible involvement of increased glycoxidation and lipid peroxidation of elastin in atherogenesis in haemodialysis patients. Nephrol Dial Transplant 17:630–636. https://doi.org/10.1093/ndt/17.4.630

    Article  CAS  PubMed  Google Scholar 

  25. Amore A, Coppo R (2002) I Immunological basis of inflammation in dialysis. Nephrol Dial Transplant 17:16–24. https://doi.org/10.1093/ndt/17.suppl_8.16

    Article  CAS  PubMed  Google Scholar 

  26. Pérez-García R, Chamond RR, de Sequera OP, Albalate M, Puerta Carretero M, Ortega M, Ruiz Caro MC, Alcazar Arroyo R (2017) Citrate dialysate does not induce oxidative stress or inflammation in vitro as compared to acetate dialysate. Nefrologia 37:630–637. https://doi.org/10.1016/j.nefro.2017.03.024

    Article  PubMed  Google Scholar 

  27. Pizzarelli F, Cantaluppi V, Panichi V, Toccafondi A, Ferro G, Farruggio S, Grossini E, Dattolo PC, Miniello V, Migliori M, Grimaldi C, Casani A, Borzumati M, Cusinato S, Capitanini A, Quercia A, Filiberti O, Dani L, Hephaestus study group (2021) Citrate high volume on-line hemodiafiltration modulates serum interleukin-6 and Klotho levels: the multicenter randomized controlled study “Hephaestus.” J Nephrol 34:1701–1710. https://doi.org/10.1007/s40620-020-00943-6

    Article  CAS  PubMed  Google Scholar 

  28. Malluche HH, Blomquist G, Monier-Faugere MC, Cantor TL, Davenport DL (2015) High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis. J Am Soc Nephrol 10:2534–2544. https://doi.org/10.1681/ASN.2014070686

    Article  CAS  Google Scholar 

  29. Sakaguchi Y, Hamano T, Obi Y, Monden C, Oka T, Yamaguchi S, Matsui I, Hashimoto N, Matsumoto A, Shimada K, Takabatake Y, Takahashi A, Kaimori JY, Moriyama T, Yamamoto R, Horio M, Yamamoto K, Sugimoto K, Rakugi H, Isaka YA (2019) A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD. J Am Soc Nephrol 30:1073–1085. https://doi.org/10.1681/ASN.2018111150

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  30. Turgut F, Kanbay M, Metin MR, Uz E, Akcay A, Covic A (2008) Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 40:1075–1082. https://doi.org/10.1007/s11255-008-9410-3

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are very grateful to Naganuma Toshiaki, a clinical engineering technician, for his contribution to this study.

Funding

This work was supported by JSPS KAKENHI under Grant Number JP19K17723.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study’s conception and design. CPP and FGF23 measurements in the blood and interpretation of the data were performed by YM and MK. Material preparation and data collection and analysis were performed by KA, NH, and TM. The first draft of the manuscript was written by KA, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Takahito Moriyama.

Ethics declarations

Conflict of interest

The authors have no competing interests to declare that are relevant to the content of this article.

Ethical approval

This study adhered to the tenets of the Declaration of Helsinki and was approved by the Medical Ethics committee of Joban Hospital, Iwaki-city, Fukushima, Japan (JHTF-2018-018, JHTF-2020-008).

Consent to participate

Consent for participation in this study was obtained on an opt-out basis from patients who had already provided written informed consent for the use of residual plasma in regular practice for research purposes.

Consent to publish

Patients provided written informed consent regarding the publication of their data and chest X-ray findings.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 144 kb)

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akiyama, Ki., Moriyama, T., Hanafusa, N. et al. Citric acid-based bicarbonate dialysate attenuates aortic arch calcification in maintenance hemodialysis patients: a retrospective observational study. J Nephrol 36, 367–376 (2023). https://doi.org/10.1007/s40620-022-01470-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40620-022-01470-2

Keywords

Navigation